
HealthGrades names top transplant centers
Second annual list recognizes 19 top performers
Topics: Surgery, Service Lines, Performance Improvement
November 17, 2011
HealthGrades named 19 U.S. hospitals to its second annual list of top transplant centers, based on the organization's review of clinical data and outcomes.
The Advisory Board congratulates the 18 member hospitals named to this year's list.
The organization used data calculated by the Scientific Registry of Transplant Recipients to evaluate the 230 adult acute care hospitals in the United States that offer heart, kidney, lung, or liver transplants.
HealthGrades reviewed transplant data collected between July 1, 2005, and December 31, 2007, to evaluate one- and three-year risk-adjusted patient survival and graft survival rates. Researchers also tracked measures related to waitlisted patients, such as mortality and the rate at which they received transplants. The hospitals that were ultimately named to the list had to have three-year patient survival rates that were "statistically higher" than expected and waitlist mortality rates that were either "statistically lower" or "not statistically different" than expected.
Three organizations were recognized for their excellence across two transplant programs. San Francisco-based California Pacific Medical Center was honored for its kidney and liver transplant programs.Shands Hospital at the University of Florida and the University of Minnesota Medical Center-Riverside were both named for their lung and liver transplant programs (HealthGrades release, 11/15; HealthGrades methodology, 11/15).
You May Also Like
-
March 01, 2009
Original Inquiry Brief
| Marketing and Planning Leadership Council
Design an inpatient transplant unit that meets the specific needs of transplant patients and the clinicians who care for them.
-
March 20, 2009
Study
| Cardiovascular Roundtable
The Future of Cardiothoracic Surgery analyzes major developments in future technologies and therapies for heart failure, thoracic surgery, CABG, valve surgery, and percutaneous values, and provides guidance for organizations on cardiothoracic surgery growth strategy.
More from the Daily Briefing
View all